2023 Annual Meeting | H330 - Best Practices for Neurology Clerkship Directors (Academic Hub)

Date Thursday 04/27/23

Time 12:00 PM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Academic)

Director(s) Erin Furr-Stimming, MD, FAAN

Topic(s) General Neurology, Leadership

Learning Objectives Participants should become familiar with the common challenges we face as neurology clerkship directors, including strategies to optimize your clerkship and minimize burnout (and yes, we will have unicorns too), and protected time, curricular guidelines, grading, and professional development. Participants are encouraged to discuss their own challenges/struggles and brainstorm with their fellow clerskship directors.

CME Available 0.00 CME credit

Core Competencies Professionalism

Program Level Intermediate

Program Tracks Academic

Recommended Audience General Neurologist, Specialist Neurologist, Neurohospitalist

Teaching Styles Interactive, Audience Participation, Small Group

Event Timeline
12:00 PM - 12:45 PM EST	Speaker	Best Practices for Neurology Clerkship Directors Erin Furr-Stimming, MD, FAAN

Faculty Disclosures
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Latus Bio. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.

��ɫ��

��ɫ��